Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Role of Neutrophil Extracellular Traps in Gastrointestinal Tumors: A Narrative Review. | Int J Mol Sci | 2022 | 36613779 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition Induced in Cancer Cells by Adhesion to Type I Collagen. | Int J Mol Sci | 2022 | 36613638 | PubTator, text mining | PubMed |
| Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. | Cancers (Basel) | 2022 | 36612139 | PubTator, text mining | PubMed |
| The Multiple Roles of Periostin in Non-Neoplastic Disease. | Cells | 2022 | 36611844 | PubTator, text mining | PubMed |
| Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595795 | PubTator, text mining | PubMed |
| Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance. | Front Immunol | 2022 | 36569859 | PubTator, text mining | PubMed |
| 3CLpro inhibitors: DEL-based molecular generation. | Front Pharmacol | 2022 | 36569316 | PubTator, text mining | PubMed |
| Case report: Recurrent lung infections following treatment with pralsetinib for an elderly patient with RET-fusion positive NSCLC. | Front Oncol | 2022 | 36568233 | PubTator, text mining | PubMed |
| Evolutionary divergence in the conformational landscapes of tyrosine vs serine/threonine kinases. | Elife | 2022 | 36562610 | PubTator, text mining | PubMed |
| FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders. | Pharmaceuticals (Basel) | 2022 | 36558997 | PubTator, text mining | PubMed |
| Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics. | Molecules | 2022 | 36557840 | PubTator, text mining | PubMed |
| Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients. | Metabolites | 2022 | 36557263 | PubTator, text mining | PubMed |
| The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review. | Cancers (Basel) | 2022 | 36551737 | PubTator, text mining | PubMed |
| COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction. | Front Oncol | 2022 | 36530986 | PubTator, text mining | PubMed |
| Chlorogenic acid regulates the proliferation and migration of high-grade serous ovarian cancer cells through modulating the miR199a5p/DDR1 axis. | Acta Biochim Pol | 2022 | 36508480 | PubTator, text mining | PubMed |
| Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis. | Front Oncol | 2022 | 36505810 | PubTator, text mining | PubMed |
| PCW-A1001, AI-assisted de novo design approach to design a selective inhibitor for FLT-3(D835Y) in acute myeloid leukemia. | Front Mol Biosci | 2022 | 36504722 | PubTator, text mining | PubMed |
| MiR-199a-3p Induces Mesenchymal to Epithelial Transition of Keratinocytes by Targeting RAP2B. | Int J Mol Sci | 2022 | 36499729 | PubTator, text mining | PubMed |
| Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival. | Int J Mol Sci | 2022 | 36499305 | PubTator, text mining | PubMed |
| SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives. | Cancers (Basel) | 2022 | 36497303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=26